A Real-World Analysis in 49,485 Eyes of Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Neovascular AMD Patients

Related

• 

  Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD

  Tarek S. Hassan, MD, FASRS

  Updates from the Field

  2019

• 

  Surgical Case Conference

  Carl C. Awh, MD, FASRS

  Carl D. Regillo, MD

  Mohamed AlBahiti, MBBS, FRCSC

  Mohsin H. Ali, MD

  Nishikant J Borse, MS, FMRF, FASRS

  Jonathan S Chang, MD, FASRS

  Albert Li, MD, FASRS

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Manish Nagpal, MD, FRCS (UK) ,FASRS

  Berna Ozkan, MD

  Uriel Rubin, MD

  Jayanth Sridhar, MD

  Victor M Villegas, MD

  Christina Y Weng, MD, MBA, FASRS

  Annual Meeting Talks

  2018

• 

  Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

  Arshad M. Khanani, MD, MA, FASRS

  Annual Meeting Talks

  2018